Insider Transactions in Q2 2015 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q2 2015)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 11
2015
|
Adam H Schechter EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Direct |
10,634
-100.0%
|
$638,040
$60.44 P/Share
|
|
May 08
2015
|
Julie L. Gerberding EVP, Chief Patient Officer |
SELL
Open market or private sale
|
Direct |
38,368
-54.54%
|
$2,302,080
$60.99 P/Share
|
|
May 08
2015
|
Julie L. Gerberding EVP, Chief Patient Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
46,208
+28.0%
|
$1,617,280
$35.03 P/Share
|
|
May 04
2015
|
Bruce N Kuhlik Exe V-P & Gen Counsel |
SELL
Open market or private sale
|
Direct |
56,064
-27.15%
|
$3,363,840
$60.2 P/Share
|
|
May 04
2015
|
Bruce N Kuhlik Exe V-P & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
56,064
+21.35%
|
$2,186,496
$39.29 P/Share
|
|
May 02
2015
|
Bruce N Kuhlik Exe V-P & Gen Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
6,071
-3.88%
|
$358,189
$59.86 P/Share
|
|
May 02
2015
|
Bruce N Kuhlik Exe V-P & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
11,708
+6.96%
|
-
|
|
May 02
2015
|
Adele D Ambrose Sr.V-P & Chief Comuns Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,423
-6.84%
|
$83,957
$59.86 P/Share
|
|
May 02
2015
|
Adele D Ambrose Sr.V-P & Chief Comuns Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,818
+15.51%
|
-
|
|
May 02
2015
|
Willie A Deese Exe V-P & Pres. MMD |
SELL
Payment of exercise price or tax liability
|
Direct |
3,438
-2.8%
|
$202,842
$59.86 P/Share
|
|
May 02
2015
|
Willie A Deese Exe V-P & Pres. MMD |
BUY
Exercise of conversion of derivative security
|
Direct |
7,636
+5.86%
|
-
|
|
May 02
2015
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
SELL
Payment of exercise price or tax liability
|
Direct |
2,640
-18.13%
|
$155,760
$59.86 P/Share
|
|
May 02
2015
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Exercise of conversion of derivative security
|
Direct |
5,090
+25.9%
|
-
|
|
May 02
2015
|
Julie L. Gerberding EVP, Chief Patient Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,214
-4.79%
|
$71,626
$59.86 P/Share
|
|
May 02
2015
|
Julie L. Gerberding EVP, Chief Patient Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,818
+13.09%
|
-
|
|
May 02
2015
|
Clark Golestani EVP & Chief Info Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
854
-8.32%
|
$50,386
$59.86 P/Share
|
|
May 02
2015
|
Clark Golestani EVP & Chief Info Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,291
+18.26%
|
-
|
|
May 02
2015
|
Weir Mirian M Graddick Exe V-P, HR |
SELL
Payment of exercise price or tax liability
|
Direct |
4,488
-3.86%
|
$264,792
$59.86 P/Share
|
|
May 02
2015
|
Weir Mirian M Graddick Exe V-P, HR |
BUY
Exercise of conversion of derivative security
|
Direct |
8,654
+6.92%
|
-
|
|
May 02
2015
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,755
-11.6%
|
$103,545
$59.86 P/Share
|
|
May 02
2015
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
4,709
+23.74%
|
-
|
|
May 02
2015
|
Michael Rosenblatt Exec V-P & Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,980
-5.73%
|
$116,820
$59.86 P/Share
|
|
May 02
2015
|
Michael Rosenblatt Exec V-P & Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,818
+9.96%
|
-
|
|
May 02
2015
|
Adam H Schechter EVP & Pres-Global Human Health |
SELL
Payment of exercise price or tax liability
|
Direct |
8,709
-45.02%
|
$513,831
$59.86 P/Share
|
|
May 02
2015
|
Adam H Schechter EVP & Pres-Global Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
19,343
+50.0%
|
-
|
|
Apr 29
2015
|
Bruce N Kuhlik Exe V-P & Gen Counsel |
SELL
Open market or private sale
|
Direct |
156,902
-30.2%
|
$9,257,218
$59.79 P/Share
|
|
Apr 29
2015
|
Bruce N Kuhlik Exe V-P & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
156,902
+21.65%
|
$5,805,374
$37.93 P/Share
|
|
Apr 29
2015
|
Michael J Holston EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
95,624
-70.51%
|
$5,641,816
$59.84 P/Share
|
|
Apr 29
2015
|
Michael J Holston EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
135,624
+31.83%
|
$5,967,456
$44.63 P/Share
|
|
Apr 13
2015
|
William B Harrison Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+30.49%
|
$165,000
$33.83 P/Share
|